← 전체 보충제 목록

사카로마이세스 보울라디

Saccharomyces boulardii

📑 PubMed 24편 🦠 프로바이오틱스

📚 관련 논문 (24편)

1.
Efficacy and Safety of <em>Saccharomyces Boulardii</em> with Standard Quadruple Therapy for Eradication of <em>Helicobacter Pylori </em>in Adults: Meta-Analysis.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2025 PMID:41247686

1. J Coll Physicians Surg Pak. 2025 Nov;35(11):1440-1446. doi: 10.29271/jcpsp.2025.11.1440. Efficacy and Safety of <em>Saccharomyces Boulardii</em> with Standard Quadruple Therapy for Eradication of <em>Helicobacter Pylori </em>in Adults: Meta-Analysis. Ma F(1)(2), Huang H, Tian K, Wang W(1)(2)

2.
The impact of probiotics on Helicobacter pylori eradication with bismuth quadruple therapy: A systematic review and meta-analysis.
International journal of antimicrobial agents 2025 PMID:40865583

2. Int J Antimicrob Agents. 2025 Dec;66(6):107600. doi: 10.1016/j.ijantimicag.2025.107600. Epub 2025 Aug 25. The impact of probiotics on Helicobacter pylori eradication with bismuth quadruple therapy: A systematic review and meta-analysis. Liu YH(1), Zhang J(2), Li DH(1), Zhang YP(1), Li J(3), G

3.
Efficacy and safety of Saccharomyces boulardii CNCM I-745 for the treatment of pediatric acute diarrhea in China: a systematic review and meta-analysis.
Frontiers in cellular and infection microbiology 2025 PMID:40535538

3. Front Cell Infect Microbiol. 2025 Jun 4;15:1587792. doi: 10.3389/fcimb.2025.1587792. eCollection 2025. Efficacy and safety of Saccharomyces boulardii CNCM I-745 for the treatment of pediatric acute diarrhea in China: a systematic review and meta-analysis. McFarland LV(#)(1)(2), Li T(#)(3). A

4.
Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicobacter pylori eradication.
BMC gastroenterology 2025 PMID:40251486

4. BMC Gastroenterol. 2025 Apr 18;25(1):273. doi: 10.1186/s12876-025-03879-y. Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicobacter pylori eradication. Jiang YZ(1), Ma K(1), Cui C(1), Li ZY(1), Wang XY(2). Author information: (1)Department of Gastroentero

5.
Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis.
Frontiers in cellular and infection microbiology 2025 PMID:40012609

5. Front Cell Infect Microbiol. 2025 Feb 12;15:1441185. doi: 10.3389/fcimb.2025.1441185. eCollection 2025. Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis. Li M(1), Xie Y(1). Author information: (1)Department of G

6.
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes.
Gut microbes 2024 PMID:38778521

6. Gut Microbes. 2024 Jan-Dec;16(1):2356279. doi: 10.1080/19490976.2024.2356279. Epub 2024 May 22. The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes. Rahman MN(1)(2), Barua N(1), Tin MCF(3), Dharmarat

7.
The effectiveness of probiotics as an adjunct therapy in patients under mechanical ventilation: an umbrella systematic review and meta-analysis.
Food & function 2024 PMID:38771159

7. Food Funct. 2024 Jun 4;15(11):5737-5751. doi: 10.1039/d3fo04653b. The effectiveness of probiotics as an adjunct therapy in patients under mechanical ventilation: an umbrella systematic review and meta-analysis. Anvarifard P(1), Anbari M(1), Ghalichi F(2), Ghoreishi Z(3)(4), Zarezadeh M(1)(3).

8.
Investigating the influence of probiotics in preventing Traveler's diarrhea: Meta-analysis based systematic review.
Travel medicine and infectious disease 2024 PMID:38458507

8. Travel Med Infect Dis. 2024 May-Jun;59:102703. doi: 10.1016/j.tmaid.2024.102703. Epub 2024 Mar 7. Investigating the influence of probiotics in preventing Traveler's diarrhea: Meta-analysis based systematic review. Alharbi BF(1), Alateek AA(2). Author information: (1)Department of Basic Healt

9.
The effect of Saccharomyces boulardii supplementation on Helicobacter pylori eradication in children: a systematic review and meta-analysis of Randomized controlled trials.
BMC infectious diseases 2023 PMID:38102568

9. BMC Infect Dis. 2023 Dec 15;23(1):878. doi: 10.1186/s12879-023-08896-4. The effect of Saccharomyces boulardii supplementation on Helicobacter pylori eradication in children: a systematic review and meta-analysis of Randomized controlled trials. Liu LH(#)(1), Han B(#)(2), Tao J(3), Zhang K(3),

10.
Effectiveness and Safety of Saccharomyces Boulardii for the Treatment of Acute Gastroenteritis in the Pediatric Population: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Computational and mathematical methods in medicine 2022 PMID:36176742

10. Comput Math Methods Med. 2022 Sep 20;2022:6234858. doi: 10.1155/2022/6234858. eCollection 2022. Effectiveness and Safety of Saccharomyces Boulardii for the Treatment of Acute Gastroenteritis in the Pediatric Population: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

11.
[Study on the efficacy of combination therapy with rifaximin and Saccharomyces boulardii CNCM I-745 in patients with small intestinal bacterial overgrowth associated with long-term use of proton pump inhibitors].
Terapevticheskii arkhiv 2025 PMID:40884341

11. Ter Arkh. 2025 Aug 28;97(8):660-667. doi: 10.26442/00403660.2025.08.203301. [Study on the efficacy of combination therapy with rifaximin and Saccharomyces boulardii CNCM I-745 in patients with small intestinal bacterial overgrowth associated with long-term use of proton pump inhibitors]. [Ar

12.
Impact of Saccharomyces boulardii on acute gastrointestinal toxicities in patients undergoing pelvic radiotherapy for gynecologic cancers: a randomized controlled trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2025 PMID:40526282

12. Support Care Cancer. 2025 Jun 17;33(7):590. doi: 10.1007/s00520-025-09663-8. Impact of Saccharomyces boulardii on acute gastrointestinal toxicities in patients undergoing pelvic radiotherapy for gynecologic cancers: a randomized controlled trial. Muangwong P(1), Tharavichitkul E(1), Thiennim

13.
Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treating Clostridioides difficile infection: A randomized controlled trial.
Scientific reports 2025 PMID:40457042

13. Sci Rep. 2025 Jun 2;15(1):19326. doi: 10.1038/s41598-025-04986-2. Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treating Clostridioides difficile infection: A randomized controlled trial. Chitapanarux T(1), Wiracha U(2), Winichakoon P(3), Salee P(3), Tr

14.
A Randomized, Controlled Study Evaluating Effects of Saccharomyces boulardii in Adult Patients with Asthma.
Drug research 2025 PMID:40228543

14. Drug Res (Stuttg). 2025 Jun;75(5):162-168. doi: 10.1055/a-2564-2569. Epub 2025 Apr 14. A Randomized, Controlled Study Evaluating Effects of Saccharomyces boulardii in Adult Patients with Asthma. Dezfouli KA(1)(2), Darban M(3), Hemmati M(4), Zahir M(5), Kermanshahi MS(6), Abdolshahi A(7), Sa

15.
Saccharomyces boulardii supplementation does not affect anaerobic power gain induced by short-term sprint interval training in physically active individuals.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2025 PMID:40136227

15. Braz J Med Biol Res. 2025 Mar 24;58:e14196. doi: 10.1590/1414-431X2025e14196. eCollection 2025. Saccharomyces boulardii supplementation does not affect anaerobic power gain induced by short-term sprint interval training in physically active individuals. Hudson ASR(1)(2), Lisboa AMT(1), Andra

16.
Effectiveness and safety of vonoprazan and amoxicillin dual regimen with Saccharomyces boulardii supplements on eradication of Helicobacter pylori.
BMC gastroenterology 2024 PMID:39592940

37. BMC Gastroenterol. 2024 Nov 26;24(1):430. doi: 10.1186/s12876-024-03524-0. Effectiveness and safety of vonoprazan and amoxicillin dual regimen with Saccharomyces boulardii supplements on eradication of Helicobacter pylori. Yu J(#)(1)(2), Cui C(#)(1), Ma K(1), Yang P(1)(2), Jiang Y(1), Wang X(

17.
[A prospective randomized controlled study on probiotics for the prevention of antibiotic-associated diarrhea in infants and young children].
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2024 PMID:39467682

39. Zhongguo Dang Dai Er Ke Za Zhi. 2024 Oct 15;26(10):1108-1114. doi: 10.7499/j.issn.1008-8830.2401129. [A prospective randomized controlled study on probiotics for the prevention of antibiotic-associated diarrhea in infants and young children]. [Article in Chinese; Abstract available in Chines

18.
Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection.
Scientific reports 2024 PMID:38849408

33. Sci Rep. 2024 Jun 7;14(1):13152. doi: 10.1038/s41598-024-63894-z. Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection. Zhang Y(#)(1), Lu B(#)(2), Dong Y(1), Zhang Y(1), Du Q(1), Chen Y(3)(4), Zhang Z(5). Author inform

19.
Saccharomyces boulardii improves clinical and paraclinical indices in overweight/obese knee osteoarthritis patients: a randomized triple-blind placebo-controlled trial.
European journal of nutrition 2024 PMID:38761281

38. Eur J Nutr. 2024 Sep;63(6):2291-2305. doi: 10.1007/s00394-024-03428-5. Epub 2024 May 18. Saccharomyces boulardii improves clinical and paraclinical indices in overweight/obese knee osteoarthritis patients: a randomized triple-blind placebo-controlled trial. Dolatkhah N(1), Jafari A(2), Esla

20.
Effectiveness of phototherapy with and without probiotics for the treatment of indirect hyperbilirubinaemia in preterm neonates: a randomised controlled trial.
Paediatrics and international child health 2024 PMID:38482867

13. Paediatr Int Child Health. 2024 May;44(1):24-29. doi: 10.1080/20469047.2024.2328416. Epub 2024 Mar 14. Effectiveness of phototherapy with and without probiotics for the treatment of indirect hyperbilirubinaemia in preterm neonates: a randomised controlled trial. Nasief H(1), Alaifan MA(2), T

21.
Influence of antibiotics on the recovery and kinetics of Saccharomyces boulardii in rats.
Pharmaceutical research 1991 PMID:2062812

37. Pharm Res. 1991 Jun;8(6):796-800. doi: 10.1023/a:1015822605815. Influence of antibiotics on the recovery and kinetics of Saccharomyces boulardii in rats. Boddy AV(1), Elmer GW, McFarland LV, Levy RH. Author information: (1)Department of Pharmaceutics, University of Washington, Seattle 98195.

22.
Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy.
The Korean journal of internal medicine 2020 PMID:31830776

1. Korean J Intern Med. 2020 May;35(3):574-581. doi: 10.3904/kjim.2019.139. Epub 2019 Dec 12. Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy. Chang YW(1), Park YM(1), Oh CH(1), Oh SJ(1), Cho JH(2), Kim JW(1),

23.
Probiotics Evaluation in Oncological Surgery: A Systematic Review of 36 Randomized Controlled Trials Assessing 21 Diverse Formulations.
Current oncology (Toronto, Ont.) 2021 PMID:34940074

23. Curr Oncol. 2021 Dec 7;28(6):5192-5214. doi: 10.3390/curroncol28060435. Probiotics Evaluation in Oncological Surgery: A Systematic Review of 36 Randomized Controlled Trials Assessing 21 Diverse Formulations. Cogo E(1), Elsayed M(1), Liang V(1), Cooley K(1)(2)(3)(4), Guerin C(1), Psihogios A(

24.
Probiotics for treating acute infectious diarrhoea.
The Cochrane database of systematic reviews 2020 PMID:33295643

38. Cochrane Database Syst Rev. 2020 Dec 8;12(12):CD003048. doi: 10.1002/14651858.CD003048.pub4. Probiotics for treating acute infectious diarrhoea. Collinson S(1), Deans A(2), Padua-Zamora A(3), Gregorio GV(3), Li C(4), Dans LF(3), Allen SJ(1). Author information: (1)Department of Clinical Sci

⚠️ 면책 고지

이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.